Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Novelion (NVLN.TO)

Novelion (NVLN.TO)

0.00
-0.00 (0.00%)
52 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
DON'T BUY

Novelion(NVLN.TO)

Mar 28, 2001
Too volatile now.
Photo of Ian NakamotoIan NakamotoUnlock Rating
$31.70

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Mar 28, 2001
Biotechs carry a lot of high P/E multiples. Expect a drop in the short term.
Photo of Robert FloydRobert FloydUnlock Rating
$31.70

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Novelion(NVLN.TO)

Mar 22, 2001
At good level. Good product.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$31.25

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Mar 16, 2001
Looks attractive. Treatment works.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$35.00

Stock price when the opinion was issued

biotechnologypharmaceutical
WAIT

Novelion(NVLN.TO)

Feb 19, 2001
Excellent company but is a high multiple stock, so will have a difficult period.
Photo of Steven WipperstegSteven WipperstegUnlock Rating
$48.20

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Feb 12, 2001
Good news gave it a bounce but needs better earnings to be a good stock.
Photo of Ross HealyRoss HealyUnlock Rating
$50.80

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Feb 12, 2001
Better value now. Visodine will be approved. Likes
Photo of Mike WeirMike WeirUnlock Rating
$50.80

Stock price when the opinion was issued

biotechnologypharmaceutical
HOLD

Novelion(NVLN.TO)

Feb 05, 2001
Stock price has been cut in half.
Photo of Ian NakamotoIan NakamotoUnlock Rating
$41.80

Stock price when the opinion was issued

biotechnologypharmaceutical
WATCH

Novelion(NVLN.TO)

Feb 01, 2001
Earnings report due 1/2 weeks. At a good price, but wait to see what comes out. If good, upside will be substantial.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$38.22

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Jan 29, 2001
Good company/mngmnt. Problems = only one product (limited diversification) and no pipeline
Photo of Ted MacklinTed MacklinUnlock Rating
$43.16

Stock price when the opinion was issued

biotechnologypharmaceutical
WATCH

Novelion(NVLN.TO)

Jan 26, 2001
Has been very volatile. Visodine works and is in US and Europe market places, but some problems with billings by insurance companies, etc.
Photo of Brendan CaldwellBrendan CaldwellUnlock Rating
$44.30

Stock price when the opinion was issued

biotechnologypharmaceutical
WAIT

Novelion(NVLN.TO)

Jan 26, 2001
Stock has come down, but waiting to see if there's more growth
Photo of Brian DawsonBrian DawsonUnlock Rating
$44.30

Stock price when the opinion was issued

biotechnologypharmaceutical
STRONG BUY

Novelion(NVLN.TO)

Jan 09, 2001
No competition in their drugs. Strong partners/royalty agreements. Has been hit in the down draft. Expect a launch of their billion dollar drug
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$38.20

Stock price when the opinion was issued

biotechnologypharmaceutical
WAIT

Novelion(NVLN.TO)

Dec 20, 2000
2 issues 1) Ins. Cos not sure how to pay 2( Doctors' charges are twofold. Sales slower than expected
Photo of Richard StoneRichard StoneUnlock Rating
$44.75

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Dec 15, 2000
Still have to prove themselvesToo high a multiple.Caution
Photo of Jonathen Wellum, B. Comm, B. ScJonathen Wellum, B. Comm, B. ScUnlock Rating
$43.95

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 166 to 180 of 190 entries
The ultimate 360° Tracker Your financial life in one place, automatically

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica